Fas (Apo-1/CD95) and Fas ligand interaction between gastric cancer cells and immune cells

Journal of Gastroenterology and Hepatology (Australia)

Volumn 17, Issue 1, 2002, Pages 32-38

  Lee, Tae Bum ^a   Min, Young Don ^a   Lim, Sung Chul ^a   Kim, Kyung Jong ^a   Jeon, Ho Jong ^a   Choi, Seok Min ^a   Choi, Cheol Hee ^a  

^a Chosun University College of Medicine   (South Korea)

Author keywords

Fas; Fas ligand; Gamma interferon; Gastric cancer cells; Tumor infiltrating lymphocytes

Indexed keywords

FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; MESSENGER RNA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; COCULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOMA; TUMOR ASSOCIATED LEUKOCYTE;

EID: 0036231324     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2002.02657.x     Document Type: Article

References (34)

1. Early gastric carcinoma with focal advanced cancer: An articular subtype of gastric carcinoma
2. Melanoma cell expression of Fas (Apo-1/CD95) ligand: Implications for tumor immune escape
3. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand
4. Expression of Fas ligand in liver metastases of human colonic adenocarcinomas
5. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand expressing tumor cells - A mechanism of immune evasion?
6. The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma
7. Human lung carcinoma express Fas ligand
8. Fas ligand expression by astrocytoma in vivo: Maintaining immune privilege in the brain
9. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis
10. Fas and Fas-ligand expression in human pancreatic cancer
11. Expression of apoptotic regulatory molecules in renal cell carcinoma. Elevated expression of Fas ligand
12. Fas/Fas ligand interaction in human colorectal hepatic metastases: A mechanism of hepatocyte destruction to facilitate local tumor invasion
13. Apoptosis, Fas and Fas-ligand expression in melanocytic tumors
14. 2-Chloro-2′-deoxyadenosine induces apoptosis through the Fas/Fas ligand pathway in human leukemia cell line MOLT-4
15. The role of Fas-mediated apoptosis in chronic myelogenous leukemia
16. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction
17. Simultaneous expression of Fas and nonfunctional Fas ligand in Ewing's sarcoma
18. Molecular structure of the human cytoplasmic beta-actin gene: Interspecies homology of sequences in the introns
19. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
20. A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity
21. Use of avidin-biotinperoxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures
22. Fas ligand mediated activation induced cell death in human T lymphocytes
23. The Fas death factor
24. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines
25. Fas expression and function in normal and malignant breast cell lines
26. Interferon-gamma modulates a p53-independent apoptotic pathway and apoptosis-related gene expression
27. Interferon-gamma induces Ice gene expression and enhances cellular susceptibility to apoptosis in the U937 leukemia cell line
28. INF-gamma induces cell growth inhibition by Fas-mediated apoptosis. Requirement of STAT1 protein for up-regulation of Fas and FasL expression
29. Nitric oxide sensitizes ovarian tumor cells to Fas-induced apoptosis
30. Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells
31. Expression of Fas (APO-1/CD95) in tumor-infiltrating and peripheral blood lymphocytes in patients with renal cell carcinoma
32. Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x (L)
33. Coexpression of FAS and FAS-ligand in chronic pancreatitis: Correlation with apoptosis
34. Fas receptor counterattack against tumor-infiltrating lymphocytes in vivo as a mechanism of immune escape in gastric carcinoma